Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

May 30, 2019
FDA’s Top 483 Observations for 2018: A Reflection of Industry’s…
Understanding industry’s compliance direction, and how this data can help evaluate the capability and… Read More
May 9, 2019
Meet the Expert: Marc Klinkhamer
Meet Marc Klinkhamer, a Principal Consultant and medical device expert based out of ProPharma… Read More
April 11, 2019
Utilizing an Agile Framework When Implementing ATMPs
Agile methodology presents a solution for organizations needing to address the timeline constraints of… Read More
More Articles

UPCOMING Events

June 28, 2019
Dutch Biotech Event 2019 – HollandBIO
Whether you’re working at a biotech startup, scale-up, runner-up or an established multinational, you do not... Read More
July 25, 2019
ISPE San Francisco 25th Annual Fun Day
Our team looks forward to this event each year, and we can’t wait to celebrate the 25th anniversary with... Read More
September 09, 2019
Cell & Gene Therapy Conference
Meet ProPharma Group at the Cell and Gene Therapy Conference for Bioprocessing and Commercialization, part of ... Read More
All Events
Contact Us